NASDAQ: GYRE - Gyre Therapeutics, Inc.

六个月盈利: -27.35%
股息率: 0.00%

促销时间表 Gyre Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. It offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under phase 3 studies for dermatomyositis and systemic sclerosis-associated interstitial lung disease, pneumoconiosis, and diabetic kidney disease.

更多详情
The company is also involved the development of F351 (Hydronidone), a structural derivative of ETUARY (Pirfenidone), under Phase 3 studies for the treatment of chronic hepatitis B liver fibrosis; and under Phase 1 studies for liver fibrosis associated with nonalcoholic associated steatohepatitis. In addition, its development pipeline includes F573, under Phase 2 studies for the treatment of acute/acute-on-chronic liver failure; F528, under preclinical stage for the treatment of chronic obstructive pulmonary disease; and F230, under preclinical stage for the treatment of pulmonary arterial hypertension. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2006-04-12
ISIN US4037831033
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 25.05
Сайт https://www.gyretx.com
Цена ао 8.79
每日价格变化: +0.22% (9.09)
每周价格变化: -6.18% (9.71)
每月价格变化: -20.85% (11.51)
3个月内价格变化: -26.83% (12.45)
六个月内的价格变化: -27.35% (12.54)
每年价格变化: -47.88% (17.48)
3年内价格变化: +569.85% (1.36)
5年内价格变化: -21.06% (11.54)
年初以来价格变化: -28.04% (12.66)
所有参数

低估

姓名 意义 年级
P/S 12.25 1
P/BV 13.16 1
P/E 107.16 1
EV/EBITDA 79.49 1
全部的: 1.88

效率

姓名 意义 年级
ROA, % 9.99 3
ROE, % 50.89 10
全部的: 5.33

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0.5 5
全部的: 2.22

责任

姓名 意义 年级
Debt/EBITDA 0.0989 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 3204.91 10
盈利能力 Ebitda, % -283.67 0
盈利能力 EPS, % -126.61 0
全部的: 2
更多详情

机构 体积 分享, %
Renaissance Technologies, LLC 39379 0.1
Geode Capital Management, LLC 17250 0.05
Vanguard Group Inc 13793 0.04
Blackrock Inc. 10250 0.03
Citigroup Inc. 7748 0.02
Morgan Stanley 6516 0.02
Kynam Capital Management, LP 6004 0.02
Northern Trust Corporation 5761 0.02
State Street Corporation 4840 0.01
Nantahala Capital Management, LLC 4520 0.01

ETF分享, %本年盈利能力, %股息, %
iShares Morningstar Small Cap Value ETF 0.00477 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.00477 201.65 2.50476
iShares Morningstar Small-Cap ETF 0.00416 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00416 391.25 1.60498
iShares Morningstar Small-Cap Growth ETF 0.00411 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.00411 587.89 0.72598
0211.871.61

导师 职称 支付 出生年份
Dr. Han Ying Ph.D. CEO & Director 10.5k 1966 (59 年)
Mr. Songjiang Ma President & Director N/A 1956 (69 年)
Ms. Ruoyu Chen Chief Financial Officer 121.35k 1971 (54 年)
Mr. Weiguo Ye Chief Operating Officer 274.62k 1978 (47 年)
Ms. Seline E. Miller CPA Senior Vice President of Finance N/A 1970 (55 年)

地址: United States, San Diego. CA, 12770 High Bluff Drive - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.gyretx.com